The CHEMIMAGE EXECUTIVE TEAM
Our executive management team represents decades of experience in Chemical Imaging, engineering, research and materials science—perhaps one of the most “hands-on” management teams you’ll ever encounter.
| |
 Jim McGlone - President
Mr. Jim McGlone joined ChemImage as President in 2008. Prior to joining ChemImage, McGlone was President of Galil Medical where he drove the expansion of Galil’s cryotherapy business. McGlone was also the President of Oncura which was a joint venture between General Electric (NYSE:GE) and Galil Medical, Ltd. Prior to joining Galil Medical, |
 |
 Charles Gardner, Ph.D - Vice President of Engineering
Dr. Charles Gardner joined ChemImage Corporation in 2001 as a Senior Project Manager. In this position, he led the development of several laboratory and field-transportable spectroscopic instruments for chemical and biological agent detection and for the examination of forensic evidence. In addition, he was the Principal Investigator for a multi-year SBIR project to develop robot-based detection and identification systems for hazardous and explosive materials. |
|
 Jeffrey K. Cohen, MD - ChemImage Board of Directors
Dr. Jeffrey K. Cohen is President of the Triangle Urological Group in Pittsburgh, PA, and also serves as Director of the Division of Urology at Allegheny General Hospital and associate professor of surgery at Drexel University/Allegheny General Hospital. Certified by the American Board of Urology, Dr. Cohen is actively involved in researching new technologies for urological disorders and has been instrumental in pioneering cryosurgery for the treatment of prostate and renal disorders. |
|
 John Belechak - Chief Operating Officer
Mr. John Belechak is the Chief Operating Officer and has been with ChemImage Corporation since 1998. Throughout his career with ChemImage, Mr. Belechak has served at the Director level within Finance, Operations and Human Resources.
He was recently promoted to Chief Operating Officer in October 2007.
|
|
 John Maier, Ph.D, MD - Vice President Biomedical Research
Dr. John Maier joined the ChemImage Corporation in 2002 as a Senior Biomedical Scientist and is the operational leader of the biomedical applications group. Dr. Maier’s focus is working with our biomedical applications group in exploring and developing applications which will ultimately impact clinical medicine. The work of the biomedical applications group involves technology development and assessment with a focus on chemical imaging of biologically relevant samples. |
|
 Patrick Treado, Ph.D - Founder, CTO, Chief Scientist
Dr. Patrick Treado is the Founder of ChemImage Corporation. Since 2004, he has served as the Chief Technology Officer and Chief Scientist of ChemImage. Dr. Treado is an analytical spectroscopist and recognized leader who has pioneered the field of chemical imaging. Dr. Treado is the author of over 150 publications and patents on chemical imaging technology, methodology and applications. |
|
Ryan J. Priore, Ph.D – Director of Applications & Contract Services
Dr. Ryan J. Priore joined the ChemImage Corporation in 2008 as a Senior Scientist and is the operational leader of the applications group. Dr. Priore and the applications group is responsible for exploring and developing pharmaceutical chemical imaging applications as well as delivering high quality chemical imaging contract services. |
|
 Dr. Thomas C. Voigt - Executive Vice President
Dr. Voigt is the head of one of the four lines of business (LOB) at ChemImage “Ingredient-Specific Particle Size Analysis - ISPS” and he is also the operational leader of the functional area “Imaging Technology”. As the head of ISPS, his focus is the establishment of a worldwide business for ISPS in the company. He also leads the group of Imaging Technology to apply and implement novel approaches to ChemImage’s LC-based intelligent optical tuners, especially for Raman, Fluorescence, and Near Infrared chemical imaging applications of all four LOB’s of ChemImage. |